Lexicon Pharmaceuticals (LXRX) Net Margin Growth (3y) (2013 - 2024)
Lexicon Pharmaceuticals (LXRX) Net Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-914,617.00 |
| Jun 30, 2024 |
438,611.00 |
| Mar 31, 2024 |
7.37 Mn |
| Dec 31, 2023 |
-612,456.00 |
| Jun 30, 2023 |
26.42 Mn |
| Dec 31, 2021 |
912,120.00 |
| Jun 30, 2021 |
-749,548.00 |
| Mar 31, 2021 |
-7.76 Mn |
| Dec 31, 2020 |
10,064.00 |
| Jun 30, 2020 |
-27.85 Mn |
| Mar 31, 2020 |
-60,230.00 |
| Dec 31, 2019 |
-48,859.00 |
| Jun 30, 2019 |
-5,516.00 |
| Mar 31, 2019 |
-64,684.00 |
| Dec 31, 2018 |
-16,642.00 |
| Sep 30, 2018 |
585,477.00 |
| Jun 30, 2018 |
728,650.00 |
| Mar 31, 2018 |
140,946.00 |
| Dec 31, 2017 |
-5,732.00 |
| Sep 30, 2017 |
962,168.00 |
